Biotech News

SI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026

Si-Bone (SIBN)Si-BoneEarnings

SAN JOSE, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ: SIBN), a global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the third quarter of 2026 after market close on

Related news

Si-Bone

Spinopelvic Procedural Solutions SI-BONE is a global medical-device company developing procedural solutions for patients with compromised bone, with a particular focus on the sacropelvic and spinopelvic anatomy. iFuse Technology Platform Its portfolio is built around the iFuse family of implants and instruments. Products include...

Recent company news

Stock data

Close
23.75 USD
Market cap
621.33M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States